Clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel
RxNorm 1540241
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1540241 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Benzoyl peroxide 0.05 mg/MG / clindamycin phosphate 0.012 mg/MG Topical Gel
(Atom ID: 12332913)
SYPrescribable
Synonym (SY):
Benzoyl peroxide 5 % / clindamycin phosphate 1.2 % Topical Gel
(Atom ID: 6343873)
PSNPrescribable
Prescribable Name (PSN):
Clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel
(Atom ID: 7246354)
Patient Education
Clindamycin and Benzoyl Peroxide Topical
The combination of clindamycin and benzoyl peroxide is used to treat acne. Clindamycin and benzoyl peroxide are in a class of medications called topical antibiotics. The combination of clindamycin and benzoyl peroxide works by killing the bacteria that cause acne.
[Learn More]
* Please review the disclaimer below.